Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for hemodynamic stability in elderly thoracic surgery
NCT07064408Completed
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Jun 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in hemodynamic instability and postoperative delirium (POD) (2 arms), sponsored by The Fourth Hospital of Hebei Medical University. Primary endpoint: Maximum Decrease in Mean Arterial Pressure During Anesthesia Induction. Started Jun 2023; status: completed.
02
Drugs
esketamine
03
Conditions
hemodynamic instabilitypostoperative delirium (POD)
Beyond the preview
Go deeper on NCT07064408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07064408.